American Well (NYSE:AMWL) Upgraded to Hold at Wall Street Zen

Wall Street Zen upgraded shares of American Well (NYSE:AMWL) from a sell rating to a hold rating in a research note issued to investors on Saturday morning.

Other research analysts also recently issued reports about the company. Wells Fargo & Company lowered their target price on American Well from $12.00 to $9.00 and set an “overweight” rating for the company in a research report on Wednesday, November 5th. Morgan Stanley dropped their price objective on American Well from $10.50 to $6.00 and set an “equal weight” rating for the company in a report on Thursday, December 18th. Weiss Ratings reiterated a “sell (e+)” rating on shares of American Well in a research note on Wednesday, January 21st. Finally, Stifel Nicolaus decreased their price objective on shares of American Well from $6.00 to $5.00 and set a “hold” rating for the company in a report on Friday. One equities research analyst has rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $7.42.

American Well Stock Performance

Shares of NYSE:AMWL opened at $5.38 on Friday. The firm has a market cap of $87.99 million, a price-to-earnings ratio of -0.90 and a beta of 1.36. The business has a 50-day simple moving average of $4.68 and a two-hundred day simple moving average of $5.45. American Well has a fifty-two week low of $3.71 and a fifty-two week high of $12.95.

American Well (NYSE:AMWL) last released its quarterly earnings data on Thursday, February 12th. The company reported ($1.52) earnings per share for the quarter, beating the consensus estimate of ($1.59) by $0.07. The firm had revenue of $55.31 million during the quarter, compared to analysts’ expectations of $52.71 million. American Well had a negative net margin of 38.38% and a negative return on equity of 34.07%. As a group, research analysts predict that American Well will post -9.34 earnings per share for the current year.

Insider Buying and Selling

In related news, insider Dmitry Zamansky sold 6,243 shares of the business’s stock in a transaction on Friday, January 2nd. The shares were sold at an average price of $4.85, for a total transaction of $30,278.55. Following the completion of the transaction, the insider directly owned 191,468 shares in the company, valued at $928,619.80. The trade was a 3.16% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In the last ninety days, insiders have sold 14,633 shares of company stock worth $67,972. Insiders own 11.82% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Headlands Technologies LLC acquired a new position in shares of American Well during the 2nd quarter valued at about $39,000. Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in American Well in the 3rd quarter valued at about $62,000. Prelude Capital Management LLC purchased a new stake in American Well during the 3rd quarter worth approximately $86,000. Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of American Well in the second quarter worth $89,000. Finally, Engineers Gate Manager LP purchased a new position in American Well in the second quarter valued at $101,000. 56.05% of the stock is owned by hedge funds and other institutional investors.

Key Stories Impacting American Well

Here are the key news stories impacting American Well this week:

• Positive Sentiment: Q4 results beat consensus: AMWL reported ($1.52) EPS vs. consensus ($1.59) and revenue of $55.31M vs. $52.71M expected — a modest beat that suggests underlying demand. Read More.
• Neutral Sentiment: Earnings call and transcript available; analysts and media are parsing commentary for signs of margin improvement and CAC trends. Read More.
• Neutral Sentiment: Independent write-ups (Zacks, Benzinga) provide metric-by-metric comparisons to estimates and discuss where growth drivers and cost levers may lie. Read More.
• Negative Sentiment: Guidance materially below Street expectations: Q1 revenue guide of $48.0M–$53.0M vs. consensus ~$59.9M, and FY2026 revenue guide of $195M–$205M vs. consensus ~$243.5M — the guidance shortfall is the clearest near-term driver of downward pressure on the stock. Read More.
• Negative Sentiment: Analyst action: Stifel cut its price target to $5.00 and moved to a “hold” — about a 7% downside from the current ~$5.38 level — reinforcing cautious sentiment after the outlook miss. Read More.

About American Well

American Well, operating under the trade name Amwell, is a Boston-based digital health company that develops and delivers telehealth solutions to healthcare providers, payers, employers and patients. Through its cloud-based platform, the company enables secure virtual visits, remote patient monitoring and integrated care coordination across a range of medical disciplines, including primary care, behavioral health, chronic disease management and urgent care.

The company’s core offering, the Amwell Telehealth Platform, facilitates live video consultations, asynchronous messaging, e-prescribing and electronic health record integration.